Sort
261,768 grants matching “gene therapy”
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
$1,809,984Jin Wang · Baylor College Of Medicine · U01 · FY2020 · AG
Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging
$1,809,944Carlos Cruchaga · Washington University · R01 · FY2024 · AG
Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging
$1,809,944Carlos Cruchaga · Washington University · R01 · FY2023 · AG
Cellular & Molecular Defects in Human B Cell Development
$1,809,366Charlotte Cunningham-Rundles · Icahn School Of Medicine At Mount Sinai · P01 · FY2013 · AI
Cannabinoid CB1 and CB2 receptors and drug abuse
$1,809,278Zheng-Xiong Xi · National Institute On Drug Abuse · ZIA · FY2023 · DA
Signaling to and from the Synapse
$1,808,913Richard L Huganir · Johns Hopkins University · P50 · FY2011 · MH
Healthy Aging and Senile Dementia
$1,808,854John Morris · Washington University · P01 · FY2015 · AG
Targeting cell signaling pathways to disrupt drug abuse
$1,808,602Solomon H Snyder · Johns Hopkins University · P50 · FY2020 · DA
Targeting cell signaling pathways to disrupt drug abuse
$1,808,602Valina L. Dawson · Johns Hopkins University · P50 · FY2021 · DA
Tau Metabolism in FTD: From Gene Mutations to Molecular Chaperones and Lysosomal Proteases
$1,808,602Aimee Kao · University Of California, San Francisco · U54 · FY2021 · NS
Targeting cell signaling pathways to disrupt drug abuse
$1,808,602Valina L. Dawson · Johns Hopkins University · P50 · FY2022 · DA
Targeting cell signaling pathways to disrupt drug abuse
$1,808,602Solomon H Snyder · Johns Hopkins University · P50 · FY2019 · DA
Mechanistic Pharmacology of Anti-Mitotics and Apoptosis Regulation
$1,808,544Timothy J Mitchison · Harvard Medical School · P01 · FY2012 · CA
Genetic and Environmental Modifiers Of Autoimmune Disease
$1,808,501Silvia Bolland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Molecular Chaperones and DNA Replication
$1,808,468Sue H Wickner · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Characterization of the Osteosarcoma Genome
$1,808,149Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
A Massive Library of AAVs to Target Transcriptionally-Defined Primate Cell Types
$1,808,049William Richard Stauffer · University Of Pittsburgh At Pittsburgh · UH3 · FY2023 · MH
Molecular-Genetic Mechs Underlying Effects of Anti-inflammatory/Analgesic Drugs
$1,807,742Raymond Dionne · National Institute Of Nursing Research · ZIA · FY2011 · NR
Genomic Approaches for Elucidating Novel Targets for Pain and Symptom Management
$1,807,742Raymond Dionne · National Institute Of Nursing Research · ZIA · FY2011 · NR
Mechanism-Based Targeting of Mantle Cell Lymphoma
$1,807,672Selina Y Chen-Kiang · Weill Medical Coll Of Cornell Univ · P01 · FY2020 · CA
LIPOPROTEINS AND ATHEROGENESIS IN TRANSGENIC ANIMALS
$1,807,538University Of Calif-Lawrenc Berkeley Lab · P01 · FY2000 · HL
From therapeutic mechanisms to unraveling the pathophysiology of MS
$1,806,808Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Tau Metabolism in FTD: From Gene Mutations to Molecular Chaperones and Lysosomal Proteases
$1,806,742Aimee Kao · University Of California, San Francisco · U54 · FY2023 · NS
Tau Metabolism in FTD: From Gene Mutations to Molecular Chaperones and Lysosomal Proteases
$1,806,742Aimee Kao · University Of California, San Francisco · U54 · FY2025 · NS
Tau Metabolism in FTD: From Gene Mutations to Molecular Chaperones and Lysosomal Proteases
$1,806,742Aimee Kao · University Of California, San Francisco · U54 · FY2024 · NS